Unbiased AI-powered news
A 14-year-old boy died and an 18-year-old was critically injured after falling from the top of a New York City subway train on the Williamsburg Bridge on Friday. Officials said the teens were riding outside the train.
nypost.comA 14-year-old boy died and an 18-year-old was critically injured after falling from the top of a New York City subway train while crossing the Williamsburg Bridge on Friday. The two teens were riding on top of a J train when the 14-year-old fell from the bridge into a lot near Delancey Street and Lewis Street, police said.
The 18-year-old fell onto the tracks at the same location. Both were taken to Bellevue Hospital. The 14-year-old was pronounced dead there, and the 18-year-old remained in critical condition as of Saturday.
Background on subway surfing incidents Officials have reported an increase in people riding outside trains in recent years. There were 928 such reports in 2022, compared with 490 in 2019. Last year five people died in subway surfing incidents. As of May 23 this year, police recorded one subway surfing fatality and made 75 related arrests.
The mayor called the incident a preventable tragedy and said no family should receive such a call. NYC Transit President Demetrius Crichlow said the continued practice is heartbreaking and urged families and teachers to intervene. Officials have used public service announcements and media campaigns to discourage the activity and have asked social media companies to remove related videos more quickly.
Single source — no framing comparison available.
screenrant.comKent Carpenter, 73, was killed by three masked men who forced entry into his house in Sibulan on Sunday night. The attackers stole a laptop, cash and a backpack. His Filipina companion was injured and received treatment.
Retired pilot Chesley Sullenberger said on July 14, 2026, that he has early-stage Alzheimer’s disease. He described initial symptoms and expressed resolve to face the condition with his family.
Japan TimesThe University of Oxford has started an early-stage clinical trial of a vaccine targeting the Bundibugyo strain of Ebola. The trial will enroll 50 healthy adults to test safety and immune response.